Innovating Works
IMMUcan: Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL tramitó un H2020: H2020-JTI-IMI2-2017-13-two-stage IMMUcan proposes an inclusive and integrated European immuno-oncology platform. IMMUcan will access high-quality human biological material...
2019-04-23 - 2025-08-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.